Longevity & AgingRemote Monitoring and Wearables Are Reshaping How Doctors Track Inflammatory Bowel Disease
Remote patient monitoring (RPM) has grown rapidly since the COVID-19 pandemic, and this review examines how it is now being applied to inflammatory bowel disease (IBD). RPM uses tools that collect biometric, behavioral, and biochemical data outside the clinic. It is already established in cardiology, endocrinology, and psychiatry. In IBD, emerging approaches include point-of-care testing for standard biomarkers, new biomarkers drawn from sources such as mucus and sweat, and passive physiologic monitoring meant to predict and prevent relapses. The authors review the broader chronic disease literature, outline early IBD applications, and discuss the barriers that still limit wider adoption. Based on the abstract alone, this is a narrative overview rather than a trial, so it points to promise and direction rather than proven outcomes.